Effect of leptin on spatial learning, memory and blood glucose level in streptozotocin induced diabetes mellitus in male wistar albino rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20195594Keywords:
Leptin, Streptozotocin, Cognition, T maze, Diabetes mellitusAbstract
Background: Diabetes mellitus is known to cause cognitive impairment that can be possibly attributed to deficient levels of leptin in diabetic animals. This study was undertaken to study the effect of administration of leptin on spatial learning, memory and blood glucose levels in diabetic rats.
Methods: Rats were divided into three groups. The first group was the control group. Diabetes was induced in groups 2 and 3 by streptozotocin (STZ) injection (60 mg/kg) intraperitoneally. Group 2 received saline while group 3 received leptin (0.1 mg/kg) subcutaneously for 10 days from 4th day of STZ administration. Behavioural assessment was done in T maze after 21 days of the last injection of leptin. Blood glucose levels were also analysed.
Results: The number of correct arm entries decreased while time spent being immobile and time spent to reach the correct arm increased in the diabetic group when compared to the control group and correct arm entries increased while time spent immobile and time spent to reach the correct arm decreased with leptin treatment when compared to the diabetic control rats. Blood glucose levels increased in the diabetic rats while leptin administration reduced blood glucose levels in the group 3.
Conclusions: Our study suggests that leptin can improve learning and memory while also producing a slight reduction in the blood glucose levels in diabetic rats.
References
Taranum A, Shakeel M. A Study of Frequency and Factors Associated with Depression among Adult Diabetics in Urban Areas of Davangere, Karnataka. National J Community Med. 2016;7(2):111-5.
WHO, Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Available at: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/. Accessed on 3 October 2019.
http://www.who.int/features/factfiles/diabetes/en/
Gispen W, Biessels G. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 2000;23(11):542-9.
Kalra S. Cognitive impairment and diabetes. Recent Pat Endocr Metab Immune Drug Discov. 2013;7(2):155-65.
Cheng C, Tsai Y, Tsai C, Chou P, Lan T. Type 2 diabetes and anti diabetic medications in relation to dementia diagnosis. J Gerontol A Biol Sci Med Sci. 2014;69:1299-305.
Brands A, de Haan E, Kappelle L, Kessels R: The Effects of Type 1 Diabetes on Cognitive Performance: a meta-analysis diabetes. Care. 2005;28:726-35.
McCrimmon R, Frier B. Diabetes and cognitive dysfunction. Lancet. 2012;0140-6736(1012):60360-2.
Van Duinkerken E. Cognitive function in diabetes. Diapedia. 2014;6104716156:4.
Dayne B, Harvey J. Leptin: A Novel Therapeutic Target in Alzheimer's Disease? Int J Alzheimer’s Dis. 2012;594137:7.
Keiichi H, Becjer D, Silva A. Leptin Before and After Insulin Therapy in Children with New-Onset Type 1 Diabetes. J Clin Endocrinol Metab. 1999;84(5):1524-6.
Ghasemi M, Zendehbad B, Zabihi H, Hosseini M, Hadjzadeh MAR, Hayatdavoudi P, et al. Beneficial Effect of Leptin on Spatial Learning and Memory in Streptozotocin-Induced Diabetic Rats. Balkan Med J. 2016;33:102-7.
Kravitz E, Schmeidler J, Schnaider Beeri M. Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies. Endocrinol Metab Clin North Am. 2013;42(3):489-501.
Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004;53(2):474-81.
Ravona-Springer R, Luo X, Schmeidler J, Wysocki M, Lesser G, Rapp M, et al. Diabetes is associated with increased rate of cognitive decline in questionably demented elderly. Dement Geriatr Cogn Disord. 2010;29(1):68-74.
Brands AMA, Biessels GJ, de Haan EHF, Kappelle LJ, Kessels RPC. The Effects of Type 1 Diabetes on Cognitive Performance. Diabetes Care. 2005;28(3):726-35.
Sachon C, Grimaldi A, Digy JP, Pillon B, Dubois B, Thervet F: Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Intern Med. 1992;231:471-5.
Denroche HC, Huynh FK, Kieffer TJ. The Role of Leptin in Glucose Homeostasis. J Diabetes Investigation. 2012;3(2):115-29.
Heymsfield SB, Greenberg AS, Fujioka K. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose‐escalation trial. JAMA. 1999;282:1568-75.
Soliman AT, Omar M, Assem HM. Type -1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control Serum leptin concentrations in children with type. Metabolism. 2002;51:292-6.
Berti L, Kellerer M, Capp E, Haring HU. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a PI3-kinase mediated effect. Diabetologia. 1997;40:606-9.
Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. Essential role phosphatidylinositol 3-kinase in insulin-induced glucose transport and anti lipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem. 1994;269:3568-73.
Welsh GI, Foulstone EJ, Young SW, Tavare JM, Proud CG. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem J. 1994;303:15-20.
Sarmiento U, Benson B, Kaufman S, Ross L, Qi M, Scully S, DiPalma C. Morphologic and molecular changes induced by recombinant human leptin in the white and brown adipose tissues of C57BL/6 mice. Lab Invest. 1997;77:243-56.
Biessels G, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, et al. Place Learning and Hippocampal Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats. Diabetes. 1996;45:1259-66.
Rosenthal J. The Effect of Acute Hypoglycemia on Brain Function and Activation. Diabetes. 2001;50(7):1618-26.
Wang MY. Leptin therapy in insulin-deficient type I diabetes. PNAS USA. 2010;107:4813-9.
Harvey J. Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol. 2007;7(6):643-7.
Garza JC, Guo M, Zhang W, Lu XY. Leptin increases adult hippocampal neurogenesis in vivo and in vitro. J Biol Chem. 2008;283(26):18238-47.
Dagon Y, Avraham Y, Magen I, Gertler A, Ben-Hur T, Berry EM. Nutritional status, cognition, and survival: a new role for leptin and AMP kinase. J Biol Chem. 2005;280(51):42142-8.
Farooqi IS, Matarese G, Lord GM. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093-103.
